The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a targeted consultation on the indefinite recognition of the CE-mark for medical devices placed on the market in Great Britain (“GB”) (i.e., England, Scotland and Wales) (the “Consultation”), which will run until 10 April 2026. The Consultation aims to complement wider planned reforms to
In June 2025, the European Parliament (“EP”) published its draft report on “Copyright and generative artificial intelligence – opportunities and challenges” (available here). The draft report calls on the European Commission to make a series of changes to the way that copyright is protected in the age of generative AI (“GenAI”). The EP notes
On February 11, 2026, the European Data Protection Board (EDPB) and the European Data Protection Supervisor (EDPS) (jointly, the Authorities) issued a Joint Opinion on the European Commission’s proposed Digital Omnibus Regulation (Digital Omnibus). This follows their Joint Opinion of January 20, 2026 on the Digital Omnibus on AI.
The Digital Omnibus, as with
On 3 February 2026, the second International AI Safety Report (the “Report”) was published—providing a comprehensive, science-based assessment of the capabilities and risks of general-purpose AI (“GPAI”). The Report touts itself as the largest global collaboration on AI safety to date—led by Turing Award winner Yoshua Bengio, backed by an Expert Advisory Panel with nominees
AI agents have arrived. Although the technology is not new, agents are rapidly becoming more sophisticated—capable of operating with greater autonomy, executing multi-step tasks, and interacting with other agents in ways that were largely theoretical just a few years ago. Organizations are already deploying agentic AI across software development, workflow automation, customer service, and e-commerce,
Consumer protection law across EMEA continues to evolve rapidly in response to digitalization, emerging technologies (particularly AI) and the continued expansion of online commerce. As we move into 2026, regulators are preparing significant reforms that will reshape business obligations and strengthen consumer‑protection enforcement. Below is an overview of the most important developments to watch this
January brought several significant, long-awaited developments in the U.S. semiconductor policy space, marking an inflection point in how the Administration is deploying trade tools to advance national security and industrial policy objectives.
On January 14, 2026, the White House issued Presidential Proclamation 11002 (the “Proclamation”) and an accompanying Fact Sheet adopting certain measures in response to
The past month has marked a series of announcements from the Department of War (the “Department”) emphasizing rapid deployment of artificial intelligence (“AI”) industry partnerships. These announcements signal opportunities for not only the defense industrial base, but also nontraditional defense contractors focused on technology and data.
On January 9, 2026, the Department released two key
Last week, Germany’s Federal Ministry of Health has adjusted the rules governing Digital Health Applications (DiGA) once more. Key changes include new reporting obligations that require manufacturers to measure and document the success of their digital health apps. This reform adds notable operational pressure, while the reported outcomes will directly affect the prices of the
Germany has kicked off a new Pharma and MedTech Dialogue that aims to develop new policies and regulatory reform proposals to re‑establish Germany as a competitive, innovation‑friendly location for life sciences R&D and manufacturing. The outcome of this dialogue shall be the basis for a new German Pharma and MedTech Strategy.